Dyne Therapeutics (DYN) Ownership - Who owns Dyne Therapeutics?
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DYN showed earnings on July 28, 2025. You can read more about the earnings report here.